X

Xponance Portfolio holdings

AUM $16.3B Turnover 12.69%
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70
Avg Time Held
3 years
Top 10 Avg Time Held
3 years
Top 20 Avg Time Held
2.6 years

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ALTM icon
926
DELISTED
Arcadium Lithium plc
ALTM
$475K ﹤0.01%
141,497
-5,446
-4% -$22.8K
2024 Q1
1 quarter
SLAB icon
927
Silicon Laboratories
SLAB
$7.38B
$475K ﹤0.01%
4,290
-302
-7% -$37.3K
2020 Q2
16 quarters
COOP icon
928
DELISTED
Mr. Cooper
COOP
$469K ﹤0.01%
5,778
-79
-1% -$6.35K
2023 Q2
4 quarters
SYNA icon
929
Synaptics
SYNA
$4.66B
$468K ﹤0.01%
5,303
-363
-6% -$32.9K
2020 Q2
16 quarters
OZK icon
930
Bank OZK
OZK
$4.9B
$465K ﹤0.01%
11,352
-1,205
-10% -$52.4K
2020 Q2
16 quarters
MAN icon
931
ManpowerGroup
MAN
$2.42B
$463K ﹤0.01%
6,636
-1,984
-23% -$147K
2020 Q2
16 quarters
SR icon
932
Spire
SR
$4.72B
$462K ﹤0.01%
7,609
-136
-2% -$8.22K
2020 Q2
16 quarters
RARE icon
933
Ultragenyx Pharmaceutical
RARE
$1.47B
$456K ﹤0.01%
11,091
+1,279
+13% +$54.6K
2021 Q2
12 quarters
FLO icon
934
Flowers Foods
FLO
$1.27B
$455K ﹤0.01%
20,491
-2,200
-10% -$52.1K
2020 Q2
16 quarters
WSC icon
935
WillScot Mobile Mini Holdings
WSC
$2.93B
$454K ﹤0.01%
12,055
+1,144
+10% +$45.3K
2021 Q2
12 quarters
BECN icon
936
DELISTED
Beacon Roofing Supply, Inc.
BECN
$451K ﹤0.01%
4,981
+931
+23% +$89.8K
2023 Q2
4 quarters
TXNM icon
937
TXNM Energy Inc
TXNM
$6.45B
$450K ﹤0.01%
12,187
-130
-1% -$4.84K
2020 Q2
16 quarters
BPMC icon
938
DELISTED
Blueprint Medicines
BPMC
$450K ﹤0.01%
4,174
+315
+8% +$31.5K
2023 Q4
2 quarters
JXN icon
939
Jackson Financial
JXN
$8.81B
$449K ﹤0.01%
6,051
-18
-0.3% -$1.29K
2023 Q3
3 quarters
COLB icon
940
Columbia Banking Systems
COLB
$7.93B
$447K ﹤0.01%
22,496
-2,187
-9% -$41.6K
2023 Q1
5 quarters
HOG icon
941
Harley-Davidson
HOG
$2.81B
$446K ﹤0.01%
13,286
-1,794
-12% -$65.2K
2020 Q2
16 quarters
SPSC icon
942
SPS Commerce
SPSC
$3.07B
$444K ﹤0.01%
2,360
+134
+6% +$24.5K
2021 Q3
11 quarters
NSP icon
943
Insperity
NSP
$1.89B
$443K ﹤0.01%
4,860
-232
-5% -$23.5K
2020 Q2
16 quarters
RHI icon
944
Robert Half
RHI
$3.58B
$440K ﹤0.01%
6,884
-11,553
-63% -$793K
2020 Q2
16 quarters
BEPC icon
945
Brookfield Renewable
BEPC
$5.23B
$438K ﹤0.01%
15,451
-9,255
-37% -$259K
2023 Q3
3 quarters
RYN icon
946
Rayonier
RYN
$5.55B
$438K ﹤0.01%
16,583
-1,683
-9% -$46.2K
2020 Q2
16 quarters
CPRI icon
947
Capri Holdings
CPRI
$1.71B
$437K ﹤0.01%
13,221
-2,086
-14% -$75.5K
2021 Q1
13 quarters
NEOG icon
948
Neogen
NEOG
$2.65B
$436K ﹤0.01%
27,906
-1,757
-6% -$24.4K
2020 Q4
14 quarters
PAG icon
949
Penske Automotive Group
PAG
$12.8B
$435K ﹤0.01%
2,918
-1,023
-26% -$156K
2023 Q3
3 quarters
WEN icon
950
Wendy's
WEN
$1.23B
$432K ﹤0.01%
25,467
-9,843
-28% -$179K
2020 Q2
16 quarters

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.